Company / Cash per Share
ANAPTYSBIO, INC Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$7.82
FY2025
5-year range
$1.26 / $18.12
FY2021-FY2025
Trend
+68.9%
vs FY2024
Sector context
#27 of 205
Health Care
What the data says
ANAPTYSBIO, INC's cash per share of $7.82 is higher than 87% of companies in the Health Care sector (FY2025). Cash per Share has fluctuated over the past 10 years, ranging from $1.26 in FY2023 to $30.63 in FY2017.
Based on SEC 10-K filings.
7.82 in FY2025 with a 5-year CAGR of -3.2%. Top quartile in the Health Care sector.
Improved from $1.26 to $7.82 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +44.7%
- 5-Year CAGR
- -3.2%
- 10-Year CAGR
- -
Sector benchmark
Top 13% in Health CareTop 13% of 205This company $7.82 Sector average $72.93
▼
-89.3% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 68.9% year-over-year.
- Ranks #27 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2017.
- Lowest cash per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.82 | +68.9% |
| FY2024 | $4.63 | +266.9% |
| FY2023 | $1.26 | -51.1% |
| FY2022 | $2.58 | -85.8% |
| FY2021 | $18.12 | +97.2% |
| FY2020 | $9.19 | +44.7% |
| FY2019 | $6.35 | +38.0% |
| FY2018 | $4.60 | -85.0% |
| FY2017 | $30.63 | +57.6% |
| FY2016 | $19.43 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026